Bio Pharma Dive
NOVEMBER 3, 2023
The company recorded a net loss in the third quarter as it “resizes” its manufacturing footprint, and now expects revenue to come in at low end of its previous guidance.
Pharma Times
NOVEMBER 3, 2023
Since 2022, an estimated 17,000 strokes and 4,000 deaths have been prevented - News - PharmaTimes
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 3, 2023
Seres, Kronos Bio and Rani Therapeutics joined Sangamo in announcing job cuts, while private biotech LocanaBio revealed it's shutting down.
Pharmaceutical Technology
NOVEMBER 3, 2023
In May 2022, Terremoto raised $75m on Series A financing for its lysine-based covalency drug development platform.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Pharma
NOVEMBER 3, 2023
Pfizer’s plunging COVID-19 product demand has spurred a companywide cost-cutting campaign, with nearly 200 jobs now on the chopping block in Michigan. | Pfizer is cutting roughly 200 positions at its Kalamazoo site following a review of demand for its COVID-19 vaccine and antiviral Comirnaty and Paxlovid.
Pharma Times
NOVEMBER 3, 2023
Over 63,000 cancer cases were diagnosed between one and five years after referral - News - PharmaTimes
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Fierce Pharma
NOVEMBER 3, 2023
Bausch Health’s gastroenterology unit Salix Pharmaceuticals has chalked up a win in its long-running fight to fend off a generic to its irritable bowel syndrome diarrhea (IBD-D) med Xifaxan. | The D.C. federal court denied Alvogen's bid to force the FDA to grant full approval to its proposed Xifaxan generic. The agency previously gave the generic a tentative approval before some patents expire in 2029.
Pharmaceutical Technology
NOVEMBER 3, 2023
Kronos Bio joins other pharma companies in workforce reductions, cutting 19% of its employees to support clinical development.
pharmaphorum
NOVEMBER 3, 2023
Study finds higher cancer rate in patients given ‘all clear’ Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
I-Mab and HI-Bio have received breakthrough therapy designation from the US FDA for the investigational CD38 antibody, felzartamab
pharmaphorum
NOVEMBER 3, 2023
Scientists in the C-Suite: Attracting investors takes more than good science Mike.
Pharmaceutical Technology
NOVEMBER 3, 2023
Eli Lilly and Company has posted a net loss of $57.4m for Q3 2023 compared to a net income of $1.4bn in the same quarter last year.
pharmaphorum
NOVEMBER 3, 2023
Moderna swings to loss as COVID sales slump Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
The rapid rollout of direct oral anticoagulants has prevented an estimated 17,000 strokes and 4,000 deaths, says the NHS.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Intouch Solutions
NOVEMBER 3, 2023
In October 2023, we proudly observe National Disability Employment Awareness Month (NDEAM). EVERSANA INTOUCH used the opportunity to spotlight one of our remarkable employees, Emelia Patterson. Emelia embodies the spirit of diversity, inclusion, and innovation, making her a true asset to our EVERSANA INTOUCH family. Emelia Patterson, Account Director, is hard of hearing.
Pharmaceutical Technology
NOVEMBER 3, 2023
The large amendment to Poland’s Reimbursement Act (Duża Nowelizacja Ustawy Refundacyjnej, DNUR) finally came into legal force on November 1, although a small number of its regulations will only come into force in 2024 and 2025.
pharmaphorum
NOVEMBER 3, 2023
Lexeo files $100m IPO in tough listing environment Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
Getting shipments from factories to end users on time and in top condition is a major priority for pharma firms
Outsourcing Pharma
NOVEMBER 3, 2023
From Disney to the drug world, Liss Easy has had a fascinating journey to where she is now in her role as vice president and general manager of clinical operations at IQVIA.
Pharmaceutical Technology
NOVEMBER 3, 2023
The achievement for Phathom Pharmaceuticals comes after a period of delay and scrutiny by the FDA for Voquezna.
Drug Channels
NOVEMBER 3, 2023
Today’s guest post comes from Greg Morris, Chief Strategy Officer at CareMetx. Greg highlights the value of therapeutic area expertise in enhancing the performance of hub services. He explains how CareMetx's hub used its experience in the retina space to improve a new brand-name product’s launch. To learn more about the impact of hub service on brand launch success, download CareMetx’s latest report: Patient Service Trends Point the Way to Better Hub/ Provider Partnerships.
Pharmaceutical Technology
NOVEMBER 3, 2023
Driven by success of recent GLP1R-targeting drugs, there has been a surge in the number of active pipeline drugs addressing this target for type 2 diabetes.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
NOVEMBER 3, 2023
Kronos sheds staff despite positive data for cancer drug Phil.
Pharmaceutical Technology
NOVEMBER 3, 2023
Bayer and the Broad Institute of MIT and Harvard have expanded their ten-year research partnership to further develop cancer treatments.
Fierce Pharma
NOVEMBER 3, 2023
Olivia Gannon, Associate Director of Global MES and Digital Execution Systems, Life Sciences Manufacturing, Cognizant, explores how a digitalization strategy harnessing the latest innovatio | Olivia Gannon, Global MES Service Line Lead at Cognizant, explores how a digitalization strategy harnessing the latest innovations in MES technologies can help streamline life science manufacturing.
Pharmaceutical Technology
NOVEMBER 3, 2023
The European Commission (EC) has approved Gedeon Richter and Sumitomo Pharma’s Type II Variation application for RYEQO for endometriosis.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Drug Patent Watch
NOVEMBER 3, 2023
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are seventeen patents protecting… The post New patent expiration for Novartis drug LEQVIO appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
NOVEMBER 3, 2023
Oleclumab is under clinical development by AstraZeneca and currently in Phase II for Pancreatic Ductal Adenocarcinoma.
Drug Patent Watch
NOVEMBER 3, 2023
Annual Drug Patent Expirations for ONPATTRO Onpattro is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are sixteen… The post New patent expiration for Alnylam Pharms drug ONPATTRO appeared first on DrugPatentWatch - Make Better Decisions.
Pharmaceutical Technology
NOVEMBER 3, 2023
Aspacytarabine hydrochloride is under clinical development by Ayala Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
317 
Let's personalize your content